Sanofi | SNY - Sales Revenues

Stock Price
45.99
Daily Change
0.08 0.17%
Monthly
-1.67%
Yearly
-14.37%
Q2 Forecast
45.74

Sanofi reported EUR12.14B in Sales Revenues for its fiscal quarter ending in March of 2026.





Sales Change Date
AbbVie USD 16.62B 840M Dec/2025
Amgen USD 9.9B 340M Dec/2025
AstraZeneca USD 15.29B 213M Mar/2026
Bristol-Myers Squibb USD 12.5B 300M Dec/2025
Canopy Growth CAD 74.54M 7.86M Dec/2025
Corcept Therapeutics USD 202.12M 5.48M Dec/2025
Drreddys Laboratories INR 87.27B 1.82B Dec/2025
Eli Lilly USD 19.3B 1.7B Dec/2025
Galapagos EUR 900.82M 835.52M Dec/2025
Genmab DKK 1.06B 36M Dec/2025
GlaxoSmithKline GBP 7.63B 991M Mar/2026
Glaxosmithkline GBP 10.09B 1.37B Mar/2026
J&J USD 24.1B 500M Mar/2026
Merck USD 16.4B 880M Dec/2025
Novartis USD 13.11B 226M Mar/2026
Novartis USD 13.11B 750M Mar/2026
Pacira USD 196.87M 17.35M Dec/2025
Perrigo USD 1.11B 70M Dec/2025
Pfizer USD 17.58B 880M Dec/2025
Phibro Animal Health USD 373.91M 10.02M Dec/2025
Prestige Brands USD 283.44M 9.34M Dec/2025
Roche Holding CHF 15.65B 274.5M Dec/2025
Sanofi EUR 11.24B 60M Mar/2026
Sanofi EUR 12.14B 65M Mar/2026
Supernus Pharmaceuticals USD 211.6M 19.5M Dec/2025
UCB EUR 4.25B 764M Dec/2025
Zoetis USD 2.4B 0 Dec/2025